Stay updated on AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page.

Latest updates to the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page
- Check6 days agoNo Change Detected
- Check12 days agoChange DetectedThe record now presents details for the completed Phase 2 study of AK002 for antihistamine-resistant chronic urticaria, including eligibility criteria, study design, outcome measures, locations, and results-reporting dates.SummaryDifference46%

- Check20 days agoChange DetectedThe footer revision identifier was updated from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA banner announces NIH website updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check33 days agoChange DetectedThe footer site revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1 while the study page remains unavailable behind a 403 Forbidden error.SummaryDifference0.2%

- Check61 days agoChange DetectedThe detailed study record content was deleted and replaced with a 403 Forbidden page, leaving only a basic header and navigation; the page now shows a restricted access state.SummaryDifference17%

Stay in the know with updates to AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page.